Skip to content

Dermaroller for acne scar management

Evaluation of the role of microneedling therapy in the management of atrophic acne scars - MAS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/05/004619
Enrollment
20
Registered
2014-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with post acne scars

Interventions

Intervention1: Microneedling procedure: 1.5mm sterile disposable microneedling device will be used to revise acne scars for total four pass in each sitting for both cheeks. The whole process is repeat

Sponsors

IPGMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with post acne atrophic scars.

Exclusion criteria

Exclusion criteria: 1. Patients with active acne at the time of examination or with hypertrophic scars. 2. Patients with any other facial complaints. 3. Patients on oral Isotretinoin or have had oral Isotretinoin in past 6 months. 4. Patients on any other oral medications in past 1 month. 5. Patients undergone any other procedure for the scars in past 1 month. 6. Patients with unrealistic expectations and unwilling to give consent.

Design outcomes

Primary

MeasureTime frame
improvement of the scars assessed by Clinician Global IndexTimepoint: 8 months

Secondary

MeasureTime frame
Skin rejuvinationTimepoint: 8 months

Countries

India

Contacts

Public ContactGobinda Chatterjee

IPGMER

drtruptis232@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026